1. Home
  2. SGHT vs RMM Comparison

SGHT vs RMM Comparison

Compare SGHT & RMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • RMM
  • Stock Information
  • Founded
  • SGHT 2011
  • RMM 2019
  • Country
  • SGHT United States
  • RMM United States
  • Employees
  • SGHT N/A
  • RMM N/A
  • Industry
  • SGHT Medical Specialities
  • RMM Trusts Except Educational Religious and Charitable
  • Sector
  • SGHT Health Care
  • RMM Finance
  • Exchange
  • SGHT Nasdaq
  • RMM Nasdaq
  • Market Cap
  • SGHT 304.4M
  • RMM 303.8M
  • IPO Year
  • SGHT 2021
  • RMM N/A
  • Fundamental
  • Price
  • SGHT $3.76
  • RMM $15.25
  • Analyst Decision
  • SGHT Buy
  • RMM
  • Analyst Count
  • SGHT 6
  • RMM 0
  • Target Price
  • SGHT $6.80
  • RMM N/A
  • AVG Volume (30 Days)
  • SGHT 264.4K
  • RMM 66.5K
  • Earning Date
  • SGHT 11-07-2024
  • RMM 01-01-0001
  • Dividend Yield
  • SGHT N/A
  • RMM 7.33%
  • EPS Growth
  • SGHT N/A
  • RMM N/A
  • EPS
  • SGHT N/A
  • RMM 0.96
  • Revenue
  • SGHT $79,543,000.00
  • RMM N/A
  • Revenue This Year
  • SGHT $3.06
  • RMM N/A
  • Revenue Next Year
  • SGHT $10.33
  • RMM N/A
  • P/E Ratio
  • SGHT N/A
  • RMM $15.55
  • Revenue Growth
  • SGHT N/A
  • RMM N/A
  • 52 Week Low
  • SGHT $2.58
  • RMM $12.32
  • 52 Week High
  • SGHT $8.45
  • RMM $16.10
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 31.07
  • RMM 37.68
  • Support Level
  • SGHT $3.65
  • RMM $15.33
  • Resistance Level
  • SGHT $3.85
  • RMM $15.85
  • Average True Range (ATR)
  • SGHT 0.29
  • RMM 0.17
  • MACD
  • SGHT -0.04
  • RMM -0.01
  • Stochastic Oscillator
  • SGHT 7.14
  • RMM 4.78

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About RMM RiverNorth Managed Duration Municipal Income Fund Inc.

RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.

Share on Social Networks: